in children who had ≥1 PCV dose and 15.3% in children who had ≥3 PCV doses. 23
Nonv-PCV13 serotypes comprised 56.4% of all isolates. The most common serogroup/types 24 were 15 (15A, 5.1%; 15B, 10.3%; 15C, 9.6%; 15F, 0.6%), 19F (17.9%), 6A (7.1%) and 6C 25 (7.1%). Carriage of serogroup 15 was more common among vaccinated children (4.1% vs. 26 0.6%, P=0.033). Molecular typing revealed that expansion of several clones (clonal complex, 27 CC63, CC199, CC1262, CC3397) was responsible for the increase in serogroup 15. Almost 28 all CC63 and CC3397 isolates were nonsusceptible to both penicillin and erythromycin. The 29 finding highlights the emergence of serogroup 15 following PCV13 use. 30 5 Nasopharyngeal swabs were collected from children aged <5 years hospitalized in a 73 regional hospital from September 2010 to August 2013. A standardized questionnaire was 74 used to obtain the following participant information from parents of participating children: 75 demographic characteristics, number of siblings (and their ages), day care attendance, prior 76 antibiotic treatment (in the last 3 months), current antibiotic treatment, smoking habit of 77 family members, the physician's diagnosis on the screening day, medical and immunization 78 history (PCV7, PCV10 and PCV13). Young children aged <5 years who were hospitalized 79 for acute illness (e.g. respiratory illness, diarrhea) were enrolled. Children with major 80 underlying condition (e.g. immunosuppression, malignancy, chronic heart disease, chronic 81 lung disease, chronic renal disease, diabetes mellitus) were excluded. The protocol is 82 approved by the Institutional Review Board at the Hong Kong West Cluster/University of 83 Hong Kong. 84
Microbiological methods 85
Nasopharyngeal cultures were obtained with alginate-tipped swabs (Ho et al., 2011b) . 86
All specimens were obtained by trained nurses. The swabs were transferred to the 87 microbiology laboratory at the University of Hong Kong within 6 hours of collection in 88
Amies transport media (TRANSWAB per nasal; Medical Wire and Equipment, Wilts, United 89 Kingdom). For selective isolation of S. pneumoniae, nasopharyngeal swabs were inoculated 90 onto 5% horse blood agar supplemented with gentamicin (2 g/ml) and incubated in 5% CO 2 91 6 for 16 to 24 hours. The isolates were identified by colony morphology, Gram stain, optochin 92 susceptibility, bile solubility and a slide co-agglutination test (Phadebact Pneumococcus Test, 93
Remel). Susceptibility of the isolates was determined by Etest (penicillin, cefotaxime) or disc 94 diffusion method (erythromycin) (Clincal and Laboratory Standard Institute, 2014). The 95 criteria for penicillin-nonsusceptible and cefotaxime-nonsusceptible were ≥0.12µg/ml (oral 96 penicillin breakpoint) and ≥2µg/ml (nonmeningitis breakpoint). 97
Molecular studies 98
The serotypes of the S. pneumoniae isolates were determined by multiplex PCR and the 99 Quellung reaction (Ho et al., 2011a; Ho et al., 2011b) . The isolates were initially tested by a 100 sequential multiplex PCR approach (Pai et al., 2006) . Strains that could not be serotyped and 101 those that required further testing to the serotype level were then tested by the Quellung 102 method with group, type and factor antisera from the Statens Seruminstitut (Copenhagen, 103 Demark). Serotype 6C and 6D were identified by PCR assays (Ho et al., 2010 isolates were 0.125/4 g/ml (0.0024 µg/ml) and 0.125/4 µg/ml (0.00816 µg/ml), 143 respectively. Isolates with penicillin (MIC ≥0.12µg/ml), cefotaxime (MIC ≥2µg/ml), 144 erythromycin and dual penicillin/erythromycin nonsusceptibility were found among a wide 145 range of different serotypes (Table 1) . Eighteen isolates had penicillin MIC ≥4 µg/ml. They 146 belong to serotypes 19F (n=11), 19A (n=2), 15C (n=2), 15B (n=1), 6C (n=1) and 34 (n=1). 147 148 9
Changes in serotypes of carried pneumococci over time 149
The data from this study was tabulated with those from two previous studies (Table 2) . 150
Compared to the previous two groups of children, there was a small decline in overall 151 pneumococcal carriage and antibiotic-resistant pneumococcal carriage rates. Prevalence of 152 PCV7 serotypes progressively declined. In contrast, pneumococcal isolates of non-PCV13 153 serotypes, especially serogroup 15 have increased in prevalence over time (Table 2) 
Pneumococcal carriage and PCV use 160
In the current cohort (period 3), total pneumococcal carriage was not associated with 161 pneumococcal immunization status. Carriage rate was 13.5% in unvaccinated children, 14.1% 162 in children who had ≥1 PCV dose (P = 0.845) and 15.3% in children who had ≥3 PCV doses 163 Table 3 . An eBURST analysis of our isolates with all other serogroup 15 177 isolates in the MLST database was shown in Figure S1 (supplementary file). In the three time 178 period, either 15C or 15B was the most prevalent subtype. The isolates belonged to 24 179 different sequence types (STs) of which 68 isolates belonged to five clonal complexes (CCs, 180 with 6 to 27 isolates each) and 14 isolates were singletons (12 different STs). The prevalence 181 of four clones had increased over time (Figure 1 ): CC199-serotype 15B/C clone, 1.3%, 2.6% 182 and 8.3% (P < 0.001); CC1262-serotype 15B/C clone, 0%, 0.9% and 6.4% (P<0.001); 183 CC63-serotype 15A/C/F clone, 0.3%, 1.4% and 5.8% (P < 0.001); and CC3397-serotype 184 15B/C clone, 0%, 0.6% and 2.6% (P = 0.004) in period 1, period 2 and period 3, respectively. 185
The nonsusceptibility rates among serogroup 15 isolates from period 1, period 2 and period 3 186 11 were 7.1%, 32.1% and 37.5% for penicillin (P = 0.102), 50.0%, 57.1% and 47.5% for 187 erythromycin (P = 0.732), and 7.1%, 32.1% and 30.0% (P = 0. 
